Progestogens and brain: An update

Maturitas

Volumn 62, Issue 4, 2009, Pages 349-355

  Pluchino, N ^a   Cubeddu, A ^a   Giannini, A ^a   Merlini, S ^a   Cela, V ^a   Angioni, S ^b   Genazzani, A R ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Allopregnanolone; Beta endorphin; Brain; Progesterone; Progestogens

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; BETA ENDORPHIN; DROSPIRENONE; DYDROGESTERONE; ESTRADIOL; ESTRADIOL BENZOATE; ESTRADIOL VALERATE; ESTROGEN; GESTAGEN; GESTODENE; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; NOMEGESTROL ACETATE; NORETHISTERONE; PROGESTERONE;

BRAIN EDEMA; BRAIN REGION; CENTRAL NERVOUS SYSTEM; CONTINUOUS INFUSION; DRUG BLOOD LEVEL; DRUG MECHANISM; HUMAN; LOW DRUG DOSE; NEUROPROTECTION; NONHUMAN; PROGESTERONE METABOLISM; PROTEIN EXPRESSION; REVIEW; STEROIDOGENESIS; TRAUMATIC BRAIN INJURY;

ANALGESICS, OPIOID; BETA-ENDORPHIN; BRAIN; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; PREGNANOLONE; PROGESTERONE; PROGESTERONE CONGENERS; PROGESTINS; STEROIDS;

EID: 67349283350     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2008.11.023     Document Type: Review

References (87)

1. Schumacher M., Guennoun R., Ghoumari A., et al. Novel perspectives for progesterone in hormone replacement therapy, with special reference to the nervous system. Endocr Rev 28 4 (2007) 387-439
2. Mani S. Progestins receptor subtypes in the brain: the known and the unknown. Endocrinology 149 June (6) (2008) 2750-2756
3. Tsai M.-J., and O'Malley B.-W. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 63 (1994) 451-486
4. Kastner P., Krust A., Turcotte B., et al. Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptors forms A and B. EMBO J 9 (1990) 1603-1614
5. Takimoto G.-S., Tung L., Abdel H., et al. Functional properties of the N-terminal region of progesterone receptors and their mechanistic relationship to structure. J Steroid Biochem Mol Biol 85 (2003) 209-219
6. Dijkema R., Schoonen W.-G., Teuwen R., et al. Human progesterone receptor A and B isoforms in CHO cells. I. Stable transfection of receptor and receptor-responsive reporter genes: transcription modulation by (anti)progestagens. J Steroid Biochem Mol Biol 64 (1998) 147-156
7. Hovland A.-R., Powell R.-L., Takimoto G.-S., Tung L., and Horwitz K.-B. An N-terminal inhibitory function, IF, suppresses transcription by the A-isoform but not the B-isoform of human progesterone receptors. J Biol Chem 273 (1998) 5455-5460
8. Shyamala G., Yang X., Silberstein G., Barcellos H., and Dale E. Transgenic mice carrying an imbalance in the native ratio of A to B forms of progesterone receptor exhibit developmental abnormalities in mammary glands. Proc Natl Acad Sci USA 95 (1998) 696-701
9. Shyamala G., Yang X., Cardiff R.-D., and Dale E. Impact of progesterone receptor on cell-fate decisions during mammary gland development. Proc Natl Acad Sci USA 97 (2000) 3044-3049
10. Wei L.-L., Gonzales-Aller C., Wood W.-M., Miller L.-A., and Horwitz K.-B. 5′-Heterogeneity in human progesterone receptor transcripts predicts a new amino-terminal truncated C-receptor and unique A-receptor messages. Ml Endocrinol 4 (1990) 1833-1840
11. Wei L.L., Hawkins P., Baker C., Norris B., Sheridan P.L., and Quinn P.G. An amino-terminal truncated progesterone receptor isoform, PRc, enhances progestin-induced transcriptional activity. Mol Endocrinol 10 (1996) 1379-1387
12. Camacho-Arroyo I., Perez-Palacios G., Pasapera A.-M., and Cerbon M.-A. Intracellular progesterone receptors are differentially regulated by sex steroid hormones in the hypothalamus and the cerebral cortex of the rabbit. J Steroid Biochem Mol Biol 50 (1994) 299-303
13. Guerra-Araiza C., Coyoy-Salgado A., and Camacho-Arroyo I. Sex differences in the regulation of progesterone receptor isoforms expression in the rat brain. Brain Res Bull 59 (2002) 105-109
14. Inoue T., Akahira J.-I., Takeyama J., et al. Spatial and topological distribution of progesterone receptor A and B isoforms during human development. Mol Cell Endocrinol 182 (2001) 83-89
15. Pluchino N., Luisi M., Lenzi E., et al. Progesterone and progestins: effects on brain, allopregnanolone and β-endorphin. J Steroid Biochem Mol Biol 102 (2006) 205-213
16. Camacho-Arroyo I., Guerra-Araiza C., and Cerbon M.-A. Progesterone receptor isoforms are differentially regulated by sex steroids in the rat forebrain. Neuroreport 9 (1998) 3993-3996
17. Guerra-Araiza C., Cerbon M.-A., Morimoto S., and Camacho-Arroyo I. Sex differences in the regulation of progesterone receptor isoforms expression in the rat brain during the estrous cycle. Life Sci 66 (2000) 1743-1752
18. Bethea C.-L., and Widmann A.-A. Differential expression of progestins receptor isoforms in the hypothalamus, pituitary and endometrium of rhesus macaques. Endocrinology 139 (1998) 677-687
19. Wu Y., Strawn E., Basir Z., Halverson G., and Guo S.-W. Promoter hypermethylation of progesterone receptor isoform B (PR-B) in endometriosis. Epigenetics 1 April-June (2) (2006) 106-111 [Epub April 1, 2006]
20. Trotter A., Bokelmann B., Sorgo W., et al. Follow-up examination at the age of 15 months of extremely preterm infants after postnatal estradiol and progesterone replacement. J Clin Endocrinol Metab 86 February (2) (2001) 601-603
21. Krebs C.-J., Jarvis E.-D., Chan J., Lydon J.-P., Ogawa S., and Pfaff D.-W. A membrane-associated progesterone-binding protein, 25-Dx, is regulated by progesterone in brain regions involved in female reproductive behavior. Proc Natl Acad Sci USA 97 (2000) 12816-12821
22. Labombarda F., Gonzalez S.-L., Deniselle M.-C., et al. Effects of injury and progesterone treatment on progesterone receptor and progesterone binding protein 25-Dx expression in the rat spinal cord. J Neurochem 87 (2003) 902-913
23. Phan V.-L., Miyamoto Y., Nabeshima T., and Maurice T. Age-related expression of σ1 receptors and antidepressant efficacy of a selective agonist in the senescence-accelerated (SAM) mouse. J Neurosci Res 79 (2005) 561-572
24. Monnet F.-P., and Maurice T. The σ 1 protein as a target for the non-genomic effects of neuron(active)steroids: molecular, physiological, and behavioral aspects. J Pharmacol Sci 100 (2006) 93-118
25. Monnet F.-P., Mahé V., Robel P., and Baulieu E.-E. Neurosteroids, via σ receptors, modulate the [3H]norepinephrine release evoked by N-methyl-d-aspartate in the rat hippocampus. Proc Natl Acad Sci USA 92 (1995) 3774-3778
26. Debonnel G., Bergeron R., Monnet F.-P., and de Montigny C. Differential effects of σ ligands on the N-methyl-d-aspartate response in the CA1 and CA3 regions of the dorsal hippocampus: effect of mossy fiber lesioning. Neuroscience 71 (1996) 977-987
27. Lena C., and Changeux J.-P. Allosteric modulations of the nicotinic acetyl-choline receptor. Trends Neurosci 16 (1993) 181-186
28. Valera S., Ballivet M., and Bertrand D. Progesterone modulates a neuronal nicotinic acetylcholine receptor. Proc Natl Acad Sci USA 89 (1992) 9949-9953
29. Denner L.-A., Weigel N.-L., Maxwell B.-L., Schrader W.-T., and O'Malley B.-W. Regulation of progesterone receptor-mediated transcription by phosphorylation. Science 250 (1990) 1740-1743
30. Gonzales-Vidal M.-D., Cervera-Gaviria M., Ruelas R., Escobar A., Morali G., and Cervantes M. Progesterone: protective effects on the cat hippocampal neuronal damage due to acute global cerebral ischemia. Arch Med Res 29 (1998) 117-124
31. Xu L., Sapolsky R.-M., and Giffard R.-G. Differential sensitivity of murine astrocytes and neurons from different brain regions to injury. Exp Neurol 169 (2001) 416-424
32. Goodman Y., Bruce A.-J., Cheng B., and Mattson M.-P. Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons. J Neurochem 66 May (5) (1996) 1836-1844
33. Cervantes M., González-Vidal M.-D., Ruelas R., Escobar A., and Moralí G. Neuroprotective effects of progesterone on damage elicited by acute global cerebral ischemia in neurons of the caudate nucleus. Arch Med Res 33 January-February (1) (2002) 6-14
34. Roof R.-L., Hoffman S.-W., and Stein D.-G. Progesterone protects against lipid peroxidation following traumatic brain injury in rats. Mol Chem Neuropathol 31 May (1) (1997) 1-11
35. Pettus E.-H., Wright D.-W., Stein D.-G., and Hoffman S.-W. Progesterone treatment inhibits the inflammatory agents that accompany traumatic brain injury. Brain Res 1049 (2005) 112-119
36. Melton L. What can sex hormones do for the damaged brain?. Lancet 8 September (2001) 358
37. Roof R.-L., Duvdevani R., and Stein D.-G. Gender influences outcome of brain injury-progesterone plays a protective role. Brain Res 607 (1993) 333-336
38. Roof R.-L., Duvdevani R., Braswell L., and Stein D.-G. Progesterone facilitates cognitive recovery and reduces secondary neuronal loss caused by cortical contusion injury in male rats. Exp Neurol 129 (1994) 64-69
39. Guo Q., Sayeed I., Baronne L.-M., Hoffman S.-W., Guennoun R., and Stein D.-G. Progesterone administration modulates AQP4 expression and edema after traumatic brain injury in male rats. Exp Neurol 198 (2006) 478-496
40. Moorthy K., Yadav U.-C., Siddiqui M.-R., et al. Effect of hormone replacement therapy in normalizing age-related neuronal markers in different age groups of naturally menopausal rats. Biogerontology 6 (2005) 345-356
41. Alkayed N.-J., Goto S., Sugo N., et al. Bcl-2: gene induction and effect of transgene in experimental stroke. J Neurosci 21 (2001) 7543-7550
42. Irwin R.-W., Yao J., Hamilton R.-T., Cadenas E., Brinton R.-D., and Nilsen J. Progesterone and estrogen regulate oxidative metabolism in brain mitochondria. Endocrinology 149 June (6) (2008) 3167-3175
43. Gonzalez S.-L., Labombarda F., Deniselle M.-C., et al. Progesterone neuroprotection in spinal cord trauma involves up-regulation of brain-derived neurotrophic factor in motoneurons. J Steroid Biochem Mol Biol 94 (2005) 143-149
44. Begliuomini S., Casarosa E., Pluchino N., et al. Influence of endogenous and exogenous sex hormones on plasma brain-derived neurotrophic factor. Hum Rep (2006) 1-9
45. Peters A. Structural changes in the normally aging cerebral cortex of primates. Prog Brain Res 136 (2002) 455-465
46. Ghoumari A.-M., Ibanez C., el-Etr M., et al. Progesterone and its metabolites increase myelin basic protein expression in organotypic slice cultures of rat cerebellum. J Neurochem 86 (2003) 848-859
47. Yin X., Crawford T.-O., Griffin J.-W., et al. Myelin-associated glycoprotein is a myelin signal that modulates the caliber of myelinated axons. J Neurosci 18 (1998) 1953-1962
48. Wang M.-D., Wahlström G., and Bäckström T. The regional brain distribution of the neurosteroids pregnenolone and pregnenolone sulfate following intravenous infusion. J Steroid Biochem Mol Biol 62 (1997) 299-306
49. Baulieu E.-E. Neurosteroids: a new function in the brain. Biol Cell 71 (1991) 3-10
50. Baulieu E.-E. Neurosteroids: of the nervous system, by the nervous system, for the nervous system. Recent Prog Horm Res 52 (1997) 1-32
51. Wolf O.-T., Neumenm O., and Helhammer D.-H. Effects of a two-week physiological dehydroepiandrosterone substitution on cognitive performance and well-being in healthy elderly women and men. J Clin Endocrinol Metab 82 (1997) 2363-2367
52. Schumacher M., Coirini H., and McEwen B.-S. Regulation of high affinity GABAA receptors in the dorsal hippocampus by estradiol and progesterone. Brain Res 487 (1989) 178-184
53. Genazzani A.-R., Bernardi F., Stomati M., et al. Effects of estradiol and raloxifene analog on brain, adrenal and serum allopregnanolone content in fertile and ovariectomized female rats. Neuroendocrinology 72 (2000) 162-170
54. Palumbo M.-A., Salvestroni C., Gallo R., et al. Allopregnanolone concentrations in hippocampus of prepubertal rats and female rats throughout estrous cycle. J Endocrinol Invest 18 (1995) 853-856
55. Stomati M., Bersi C., Rubino S., et al. Neuroendocrine effects of different estradiol-progestin regimens in postmenopausal women. Maturitas 15 28 (2) (1997) 127-135
56. Genazzani A.-R., Bernardi F., Pluchino N., et al. Effect of tibolone administration on central and peripheral levels of allopregnanolone and beta-endorphin in female rats. Menopause 13 1 (2006) 57-64
57. Pluchino N., Lenzi E., Casarosa E., et al. Dydrogesterone increases allopregnanolone in selected brain areas and in serum of female rats. Fertil Steril 89 May (5 Suppl) (2008) 1384-1389
58. Genazzani A.-R., Pluchino N., Begliuomini S., et al. Drospirenone increases central and peripheral beta-endorphin in ovariectomized female rats. Menopause 14 1 (2007) 63-73
59. Bernardi F., Pluchino N., Pieri M., et al. Progesterone and medroxyprogesterone acetate effects on central and peripheral allopregnanolone and beta-endorphin levels. Neuroendocrinology 83 5-6 (2006) 348-359
60. Genazzani A.-R., Petraglia F., Bergamaschi M., Genazzani A.-D., Facchinetti F., and Volpe A. Progesterone and progestins modulate beta-endorphin concentrations in the hypothalamus and in the pituitary of castrated female rats. Gynecol Endocrinol 1 1 (1987) 61-69
61. Genazzani A.-R., Petraglia F., Cleva M., et al. Norgestimate increases pituitary and hypothalamic concentrations of immunoreactive beta-endorphin. Contraception 40 5 (1989) 605-613
62. Bitran D., Purdy R.-H., and Kellogg C.-K. Anxiolytic effect of progesterone is associated with increases in cortical allopregnanolone and GABAA receptor function. Pharmacol Biochem Behav 45 (1993) 423-428
63. Bitran D., Shiekh, and McLeod M. Anxiolytic effect of progesterone is mediated by the neurosteroid allopregnanolone at brain GABAA receptors. J Neuroendocrinol 7 (1995) 171-177
64. Frye C.-A., Bayon L.-E., Pursnani N.-K., and Purdy R.-H. The neurosteroids, progesterone and 3alpha,5alpha-THP, enhance sexual motivation, receptivity, and proceptivity in female rats. Brain Res 808 (1998) 72-83
65. Corpechot C., Young J., Calvel M., et al. Neurosteroids: 3alpha-hydroxy-5alpha-pregnan-20-one and its precursors in the brain, plasma, and steroidogenic glands of male and female rats. Endocrinology 133 (1993) 1003-1009
66. Wiebe J.-P., and Kavaliers M. Analgesic effects of the putative FSH-suppressing gonadal steroid, 3{alpha}-hydroxy-4-pregnen-20-one: possible modes of action. Brain Res 461 (1988) 150-157
67. Stanczyk F.-Z. All progestins are not created equal. Steroid 68 (2003) 879-890
68. Nilsen J., and Brinton R.-D. Divergent impact of progesterone and medroxyprogesterone acetate (provera) on nuclear mitogen-activated protein kinase signaling. Proc Natl Acad Sci 100 (2003) 10506-10511
69. Morali G., Lemus A.-E., Munguia R., Garcia G.-A., Grillasca I., and Perez-Palacios G. Hormone-like behavioral effects of levonorgestrel and its metabolites in the male rat. Pharmacol Biochem Behav 73 (2002) 951-961
70. Garcia-Becerra R., Borja-Cacho E., Cooney A.-J., et al. The intrinsic transcriptional estrogenic activity of a non-phenolic derivative of levonorgestrel is mediated via the estrogen receptor-α. J Steroid Biochem Mol Biol 82 (2002) 333-341
71. Winneker R.-C., Bitran D., and Zhang Z. The preclinical biology of a new potent and selective progestin: trimegestone. Steroids 68 (2003) 915-920
72. Sitruk-Ware R. New progestagens for contraceptive use. Hum Reprod Update 12 2 (2006) 169-178
73. Genazzani A.-R., Petraglia F., Bernardi F., et al. Circulating levels of allopregnanolone in humans: gender, age, and endocrine influences. J Clin Endocrinol Metab 83 6 (1998) 2099-2103
74. Bernardi F., Pieri M., Stomati M., et al. Effect of different hormonal replacement therapies on circulating allopregnanolone and dehydroepiandrosterone levels in postmenopausal women. Gynecol Endocrinol 17 1 (2003) 65-77
75. Pluchino N., Genazzani A.-D., Bernardi F., et al. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels. Gynecol Endocrinol 20 3 (2005) 144-149
76. Lenzi E., Pluchino N., Begliuomini S., et al. Effects of nomegestrol acetate administration on central and peripheral beta-endorphin and allopregnanolone in ovx rats. J Steroid Biochem Mol Biol 110 (2008) 67-75
77. Rabe T., Kowald A., Ortmann J., and Rehberger-Schneider S. Inhibition of skin 5alpha-reductase by oral contraceptive progestins in vitro. Gynecol Endocrinol 14 (2000) 223-230
78. Yu W.-H. Survival of motoneurons following axotomy is enhanced by lactation or by progesterone treatment. Brain Res 491 (1989) 379-382
79. Etgen A.-M., and Karkanias G.-B. Estrogen regulation of noradrenergic signaling in the hypothalamus. Psychonbeuroendocrinology 19 (1994) 603-610
80. Argiolas A. Neuropeptides and sexual behaviour. Neurosci Biobehav Rev 23 (1999) 1127-1142
81. Bancroft J. The endocrinology of sexual arousal. J Endocrinol 186 (2005) 411-427
82. Wardlaw S.-L., Wehrenberg W.-B., Ferin M., Antunes J.-L., and Frantz A.-G. Effect of sex steroids on beta-endorphin in hypophyseal portal blood. J Clin Endocrinol Metab 55 (1982) 877-881
83. Fox S.-R., Harlan R.-E., Shivers B.-D., and Pfaff D.-W. Chemical characterization of neuroendocrine targets for progesterone in the female rat brain and pituitary. Neuroendocrinology 51 (1990) 276-283
84. Aleem F.-A., and McIntosh T. Menopausal syndrome: plasma levels of beta-endorphin in postmenopausal women using a specific radioimmunoassay. Maturitas 13 (1985) 76-84
85. Dufourny L., Caraty A., Clarke I.-J., Robinson J.-E., and Skinner D.-C. Progesterone-receptive beta-endorphin and dynorphin B neurons in the arcuate nucleus project to regions of high gonadotropin-releasing hormone neuron density in the ovine preoptic area. Neuroendocrinology 81 (2005) 139-149
86. Heuser I., Deuschle M., Weber B., Stalla G.-K., and Holsboer F. Increased activity of the hypothalamus-pituitary-adrenal system after treatment with the mineralocorticoid receptor antagonist spironolactone. Psychoneuroendocrinology 25 (2000) 513-518
87. Young E.-A., Lopez J.-F., Murphy-Weinberg V., Watson S.-J., and Akil H. The role of mineralocorticoid receptors in hypothalamic-pituitary-adrenal axis regulation in humans. J Clin Endocrinol Metab 83 (1998) 3339-3345